Skip to main content

Deucravacitinib

Generic name: deucravacitinib (due krav a sye ti nib)
Brand name: Sotyktu
Dosage form: oral tablet (6 mg)
Drug class: Multikinase inhibitors

Medically reviewed by Drugs.com on Nov 29, 2022. Written by Cerner Multum.

What is deucravacitinib?

Deucravacitinib is used to treat adults with moderate to severe plaque psoriasis.

Deucravacitinib may also be used for purposes not listed in this medication guide.

Deucravacitinib side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Deucravacitinib can cause the breakdown of muscle tissue, which can lead to kidney failure. Call your doctor right away if you have unexplained muscle pain, tenderness, or weakness especially if you also have fever, unusual tiredness, or dark urine.

Also call your doctor at once if you have:

Common side effects of deucravacitinib may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings

Serious infections may occur during treatment with deucravacitinib. Call your doctor right away if you have signs of infection such as: fever, chills, muscle pain, shortness of breath, weight loss, diarrhea or stomach pain, burning when you urinate, feeling very tired, skin warmth or redness, painful skin sores, or coughing up blood.

Deucravacitinib can cause the breakdown of muscle tissue, which can lead to kidney failure. Call your doctor right away if you have unexplained muscle pain, tenderness, or weakness especially if you also have fever, unusual tiredness, or dark urine.

Before taking this medicine

You should not use deucravacitinib if you are allergic to it.

Tell your doctor if you have ever had:

Tell your doctor if you are pregnant or breastfeeding.

How should I take deucravacitinib?

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the medicine exactly as directed.

Take deucravacitinib once every day, with or without food.

Swallow the tablet whole and do not crush, chew, or break it.

You will need medical tests before you start taking deucravacitinib and while taking deucravacitinib.

Store at room temperature away from moisture and heat.

Deucravacitinib dosing information

Usual Adult Dose for Plaque Psoriasis:

6 mg orally once a day

Comments:
-Limitations of use: This drug is not recommended for use in combination with other potent immunosuppressants.
-Prior to treatment initiation, patients should be evaluated for latent or active tuberculosis infection.
-The use of live vaccines during therapy with this drug is not advised.

Use: For the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy

What happens if I miss a dose?

Take the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not take two doses at one time.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking deucravacitinib?

Avoid receiving a "live" vaccine. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, varicella (chickenpox), and zoster (shingles).

What other drugs will affect deucravacitinib?

Other drugs may affect deucravacitinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Popular FAQ

Sotyktu and Otezla are both oral prescription medicines used to treat moderate-to-severe plaque psoriasis, but they work in different ways. Sotyktu blocks a protein called TYK2 (tyrosine kinase 2) to help lower inflammation and improve the severity and number of psoriasis lesions. Otezla works by blocking the phosphodiesterase type 4 (PDE4) enzyme to lower inflammation. Continue reading

Sotyktu is an oral tablet given daily that has been shown to work for at least 2 years in plaque psoriasis studies. It is meant to be taken on a daily basis, but how long you take this medicine will depend on your individual response to treatment. Continue your treatment as long as recommended by your healthcare provider. Continue reading

Sotyktu (pronounced “soh-tik-too”) is given as an oral tablet once per day, with or without food. Take it at about the same time each day. Do not crush, cut, or chew the tablets. Sotyktu is used in adults at least 18 years of age. It is not known if it is safe and effective in children. Continue reading

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.